Skip to search formSkip to main contentSkip to account menu

VB-201

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
It includes a VB-201 and a pharmaceutically acceptable carrier 1 mg to 100 mg, formulated in unit dosage form for oral… 
2011
2011
VB-201, 1-hexadecil-2-(4'-carboxibutil)-glicerol-3-fosfocolina, para su uso en el tratamiento o la prevencion de una enfermedad o… 
2011
2011
1 mg to 100 mg of VB-201, and once a day or twice a VB-201 to include a pharmaceutically acceptable carrier and, the treatment of… 
2011
2011
And oxidized lipids VB-201, methods of treatment using the co-administration of a drug with a further therapeutically active are…